02561 VISEN PHARMA-B
Trading Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2024) | |||
| Current | 4.26X | Oper Margin | N/A |
|---|---|---|---|
| LT Debt/Equity | 0.2% | Net Margin | N/A |
| Total Debt/Equity | 1.0% | Return on Equity | N/A |
| Price/Book | N/A | Return on Assets | N/A |
| (HKD 45.280) | 2024-12 | 2023-12 | 2022-12 |
| Net Profit (MHKD) | -193.81 | -275.08 | -323.99 |
|---|---|---|---|
| Net Profit Growth (%) | +29.5 | +15.1 | N/A |
| Earnings Per Share (HKD) | N/A | N/A | N/A |
| Earnings Per Share Growth (%) | N/A | N/A | N/A |
| Dividend Per Share (HKD) | No dividend | No dividend | No dividend |
| P/E* (X) | N/A | N/A | N/A |
| Yield (%) | N/A | N/A | N/A |
| Dividend Share (%) | N/A | N/A | N/A |
| Book NAV (HKD) | N/A | N/A | N/A |
| Auditors' Opinion | Unqualified | N/A | N/A |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2025-09-07 21:40:22
Latest Result
| (RMBMn) | 2025-06 | 2024-06 | Chg* (%) | |
| Cover Period (mths) | 6 | 6 | NA | |
|---|---|---|---|---|
| Operating Result | -118.02 | -83.471 | +41.4 | |
| Profit Before Taxation | -118.02 | -83.471 | +41.4 | |
| Profit /( Loss) After Taxation | -118.02 | -83.471 | +41.4 | |
| Net Profit | -118.02 | -83.471 | +41.4 | |
| Earnings Per Share () | -1.2925 | -0.9580 | +34.9 | |
| Announcement Date | 2025-08-27 | 2025-08-27 | NA |
* Annualised
Last Update Time: 2025-09-07 21:40:27
